Buy The GLP-1 Legacy on Amazon Read a Sample Chapter Who this book is for The GLP-1 Legacy has been written for people who have used, are using, or are coming to the end of treatment with GLP-1 medications such as Ozempic, Wegovy or Mounjaro
Clients with gut or inflammatory concerns often report the earliest noticeable support during this phase as BPC-157 and KPV begin supporting gut lining integrity and inflammatory balance
Tracking weekly changes in hunger, cravings, and blood sugar can help assess progress, especially since results take time and vary by person
3-O-ethyl ascorbic acid is a very stable form of vitamin C and has a high absorption capacity
Mechanistically, GLP-1 receptor agonists may exert vascular protective effects by suppressing inflammation, limiting oxidative stress, and modulating key enzymes involved in extracellular matrix remodeling ( Matrix metalloproteinases, particularly MMP-9, together with their endogenous inhibitors (TIMPs), play central roles in extracellular matrix turnover and structural vascular remodeling ( The reduction in CRP, a recognized marker of aortic stiffness, medial degeneration, and systemic inflammation, further supports the anti-inflammatory profile associated with GLP-1RA therapy
Together, dual-action control over the drive to eat and the feeling of fullness
